Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T11:35:44.771Z.
Calculation as of: 2026-10-06T11:35:44.771Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 58a2fa14633c50703c8ff5f7fcb702de1515a66dae0cc773e6a723eda01f3aaa
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
BridgeBio Pharma, Inc.
Market Cap
$12.95B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.89B
Operating Cash Flow Yield
12.58%
TTM Avg
11.54%
3Y Avg
8.16%
5Y Avg
6.55%
Market Cap
$13.19B
Operating Cash Flow Yield
0.83%
TTM Avg
2.05%
3Y Avg
2.89%
5Y Avg
3.85%
Market Cap
$12.52B
Operating Cash Flow Yield
10.53%
TTM Avg
9.40%
3Y Avg
7.78%
5Y Avg
7.08%
Market Cap
$12.49B
Operating Cash Flow Yield
2.22%
TTM Avg
1.94%
3Y Avg
1.60%
5Y Avg
1.27%
Market Cap
$12.17B
Operating Cash Flow Yield
4.16%
TTM Avg
4.21%
3Y Avg
4.31%
5Y Avg
4.31%
Market Cap
$12.00B
Operating Cash Flow Yield
10.10%
TTM Avg
10.47%
3Y Avg
10.06%
5Y Avg
11.46%
Market Cap
$14.16B
Operating Cash Flow Yield
2.85%
TTM Avg
0.87%
3Y Avg
0.87%
5Y Avg
0.87%
Market Cap
$11.47B
Operating Cash Flow Yield
19.11%
TTM Avg
17.34%
3Y Avg
16.89%
5Y Avg
18.02%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | N/A | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 12.58% | 11.54% | 8.16% | 6.55% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.83% | 2.05% | 2.89% | 3.85% |
| Baxter International Inc. (BAX)vs › | $12.52B | 10.53% | 9.40% | 7.78% | 7.08% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 2.22% | 1.94% | 1.60% | 1.27% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 4.16% | 4.21% | 4.31% | 4.31% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 10.10% | 10.47% | 10.06% | 11.46% |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 2.85% | 0.87% | 0.87% | 0.87% |
| DaVita Inc. (DVA)vs › | $11.47B | 19.11% | 17.34% | 16.89% | 18.02% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 2.57% | 2.84% | 2.78% | 2.55% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
